The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 4-year (y) update.
Richard A. Larson
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Andreas Hochhaus
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Giuseppe Saglio
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Dong-Wook Kim
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Bristol-Myers Squibb; Novartis; Wyeth
Research Funding - Bristol-Myers Squibb; Novartis; Wyeth
Saengsuree Jootar
No relevant relationships to disclose
Philipp D. Le Coutre
Research Funding - ARIAD; Novartis
Expert Testimony - ARIAD; Bristol-Myers Squibb; Novartis
Josy Reiffers
No relevant relationships to disclose
Ricardo Pasquini
No relevant relationships to disclose
Stuart L. Goldberg
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Richard E. Clark
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Expert Testimony - National Institute of Clinical Excellence - NICE UK
Charisse N. Kemp
Employment or Leadership Position - Novartis
Xiaolin Fan
Employment or Leadership Position - Novartis
Hans D. Menssen
Employment or Leadership Position - Novartis
Timothy P. Hughes
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; CSL Limited; Novartis
Hagop M. Kantarjian
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer